We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $8.34B
1-Year Est. Return 46.58%
This Fund
S&P 500
This Quarter Est. Return
+15.07%
1 Year Est. Return
+46.58%
3 Year Est. Return
+191.6%
5 Year Est. Return
+200.35%
10 Year Est. Return
+3,561.44%
AUM
$9.63B
AUM Growth
+$918M
Cap. Flow
-$168M
Cap. Flow %
-1.74%
Top 10 Hldgs %
26.47%
Holding
332
New
33
Increased
58
Reduced
182
Closed
32

Top Buys

Rank Stock Value
1
ZM icon
Zoom
ZM
+$63.9M
2
RGEN icon
Repligen
RGEN
+$44.8M
3
BLUE
bluebird bio
BLUE
+$40.1M
4
TNDM icon
Tandem Diabetes Care
TNDM
+$37.3M
5
NTRA icon
Natera
NTRA
+$37.2M

Sector Composition

Rank Sector Weight
1 Technology 26.37%
2 Healthcare 20.01%
3 Communication Services 15.46%
4 Consumer Discretionary 14.68%
5 Consumer Staples 4.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NFLX icon
1
Netflix
NFLX
$303B
$421M 4.37%
13,019,940
-679,210
-5% -$20.1M
ROKU icon
2
Roku
ROKU
$21.5B
$410M 4.26%
3,063,225
-186,888
-6% -$25.7M
AMZN icon
3
Amazon
AMZN
$2.47T
$367M 3.81%
3,969,140
-379,680
-9% -$33.6M
TSLA icon
4
Tesla
TSLA
$1.2T
$233M 2.41%
8,341,710
+1,241,340
+17% +$26.9M
OKTA icon
5
Okta
OKTA
$23.6B
$212M 2.2%
1,837,876
-63,529
-3% -$7.31M
RNG icon
6
RingCentral
RNG
$4.83B
$194M 2.01%
1,149,408
-436,416
-28% -$71.9M
SHOP icon
7
Shopify
SHOP
$169B
$189M 1.97%
4,766,270
+39,430
+0.8% +$1.33M
EXAS
8
DELISTED
Exact Sciences
EXAS
$162M 1.68%
1,750,209
-51,885
-3% -$4.56M
CHGG icon
9
Chegg
CHGG
$119M
$159M 1.65%
4,192,099
-48,877
-1% -$1.71M
AZUL
10
DELISTED
Azul
AZUL
$147M 1.52%
3,427,488
-53,829
-2% -$2.07M
FRPT icon
11
Freshpet
FRPT
$3.04B
$143M 1.48%
2,413,426
-98,254
-4% -$5.23M
DXCM icon
12
DexCom
DXCM
$29.2B
$141M 1.47%
2,584,252
-76,980
-3% -$3.65M
MDB icon
13
MongoDB
MDB
$26.4B
$139M 1.44%
1,056,045
-102,878
-9% -$13.5M
SHAK icon
14
Shake Shack
SHAK
$2.55B
$134M 1.39%
2,255,820
-9,894
-0.4% -$711K
MLM icon
15
Martin Marietta Materials
MLM
$34.4B
$128M 1.33%
457,552
-8,186
-2% -$2.18M
SRPT icon
16
Sarepta Therapeutics
SRPT
$1.65B
$122M 1.26%
943,811
-6,630
-0.7% -$669K
ADSK icon
17
Autodesk
ADSK
$52.1B
$115M 1.2%
629,009
-33,890
-5% -$5.49M
ISRG icon
18
Intuitive Surgical
ISRG
$127B
$114M 1.19%
580,137
-3,942
-0.7% -$738K
HUBS icon
19
HubSpot
HUBS
$12.9B
$113M 1.17%
713,507
-13,747
-2% -$2.1M
EPAM icon
20
EPAM Systems
EPAM
$5.57B
$109M 1.13%
512,165
-41,757
-8% -$8.22M
ALNY icon
21
Alnylam Pharmaceuticals
ALNY
$38.1B
$108M 1.12%
936,479
-17,626
-2% -$1.76M
VCYT icon
22
Veracyte
VCYT
$4.43B
$105M 1.09%
3,771,959
-52,667
-1% -$1.36M
NYT icon
23
New York Times
NYT
$12.4B
$101M 1.05%
3,132,317
-24,330
-0.8% -$756K
TDOC icon
24
Teladoc Health
TDOC
$1.67B
$98.9M 1.03%
1,180,826
-138,213
-10% -$10.5M
TMUS icon
25
T-Mobile US
TMUS
$194B
$98.5M 1.02%
1,256,187
-12,451
-1% -$980K

Similar funds

Gilder Gagnon Howe & Co's Q4 2019 Portfolio in Review

As of Q4 2019, Gilder Gagnon Howe & Co held 332 positions worth $9.63B, up 11% from $8.72B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Gilder Gagnon Howe & Co's Q4 2019 filing shows 33 new, 58 increased, 182 reduced and 32 closed positions. Its largest new stake was Repligen: 532,930 shares worth $49.3M. The largest sale was Twitter, Inc., an estimated $94.8M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Communication Services.

  • Gilder Gagnon Howe & Co's largest Q4 2019 buy was Repligen: 532,930 shares worth $49.3M.
  • Gilder Gagnon Howe & Co added most to Zoom in Q4 2019, an estimated $63.9M increase.
  • Gilder Gagnon Howe & Co's biggest Q4 2019 reduction was Twitter, Inc., cutting an estimated $94.8M.
  • Gilder Gagnon Howe & Co fully exited Bandwidth Inc in Q4 2019, selling an estimated $30.3M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 26% of its $9.63B portfolio in Q4 2019.
  • Gilder Gagnon Howe & Co opened 33 new positions and closed 32 in Q4 2019.
  • Gilder Gagnon Howe & Co's portfolio value rose 11% quarter-over-quarter to $9.63B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2019, filed 14 Feb 2020.